XTAI
1310
Market cap170mUSD
Jul 09, Last price
10.35TWD
1D
-6.33%
1Q
0.49%
Jan 2017
-48.12%
Name
Taiwan Styrene Monomer Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Taiwan Styrene Monomer Corporation, through its various subsidiaries, is a key player in the global manufacturing and supply of essential chemical substances. The company's product portfolio encompasses styrene monomer, para-diethyl benzene, toluene, methyl benzene, hydrogen, and ethyl benzene, which are distributed across Taiwan, the United States, and other international markets. Its business operations are segmented into three distinct areas: Plastics, Investment, and a general 'Other' category. These chemical offerings are integral to a wide array of industries, including electrical appliances, machinery, electronics, automotive production, and packaging. The corporation's primary customers are producers of polystyrene, acrylonitrile-butadiene-styrene (ABS) resins, and synthetic rubber. Beyond its core chemical manufacturing, Taiwan Styrene Monomer Corporation boasts a diversified service offering. This includes the wholesale distribution of medical apparatus and the provision of specialized piping engineering solutions. The company also extends into real estate, overseeing the development and leasing of residential and industrial properties, and operates hotel establishments. Further diversifying its activities, it manufactures electrical components and provides consulting expertise in fields such as education, information technology, software, and data storage. Established in 1979, the company's corporate headquarters are situated in Taipei City, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||